Literature DB >> 16695628

METHEMALBUMIN. II. EFFECT OF PAMAQUINE AND QUININE ON PATHWAYS OF HEMOGLOBIN METABOLISM.

W D Blake1.   

Abstract

Entities:  

Year:  1948        PMID: 16695628      PMCID: PMC438904          DOI: 10.1172/JCI101954

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS.

Authors:  I J Pass; S Schwartz; C J Watson
Journal:  J Clin Invest       Date:  1945-05       Impact factor: 14.808

2.  SIGNIFICANCE OF CEPHALIN-CHOLESTEROL FLOCCULATION TEST IN MALARIAL FEVER.

Authors:  S A Guttman; H R Potter; F M Hanger; D B Moore; P S Pierson; D H Moore
Journal:  J Clin Invest       Date:  1945-05       Impact factor: 14.808

3.  METHEMALBUMIN. I. APPEARANCE DURING ADMINISTRATION OF PAMAQUINE AND QUININE.

Authors:  M Rosenfeld; C G Zubrod; W D Blake; J A Shannon
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

4.  ACUTE HEMOLYTIC ANEMIA FROM THE SULFONAMIDES.

Authors:  C L Fox; R Ottenberg
Journal:  J Clin Invest       Date:  1941-09       Impact factor: 14.808

5.  HEPATIC DYSFUNCTION IN MALARIA.

Authors:  I A Mirsky; R V Brecht; L D Williams
Journal:  Science       Date:  1944-01-07       Impact factor: 47.728

  5 in total
  3 in total

1.  STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VIII. THE PHYSIOLOGICAL DISPOSITION OF PAMAQUINE.

Authors:  C G Zubrod; T J Kennedy; J A Shannon
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

2.  Malaria; with special reference to certain experimental, clinical, and chemotherapeutic investigations; chemotherapy.

Authors:  N H FAIRLEY
Journal:  Br Med J       Date:  1949-10-22

3.  STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. IX. EFFECT OF PAMAQUINE ON THE BLOOD CELLS OF MAN.

Authors:  D P Earle; F S Bigelow; C G Zubrod; C A Kane
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.